General Info
Chris Behrenbruch is a CEO with a strong focus on purpose and values-leadership, particularly in running a publicly listed company. His investment is centered on late-stage pipeline assets, with a geographical preference in healthcare and biotechnology. He is actively involved in the development of targeted therapies for diseases like prostate, kidney, brain cancer, and bone marrow conditioning. The investment check size and partnership styles are not explicitly stated on his profiles.
Location:
Country: Canada
Industries:
Investment Regions: EA
Investment Stages: pre-seed, seed
angel-individual
EA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Search results show Christian (Chris) Behrenbruch is active as CEO of Telix and involved in company activities and likely investments; there are multiple 2025 references including Jan-Aug 2025 indicating recent activity. The investor invested in Telix-related developments and company activities (startup not applicable). The most recent activity within 6 months places him in very-active.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Chris Behrenbruch
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI